Suppr超能文献

来自小鼠诱导多能干细胞的功能性肌源性植入。

Functional myogenic engraftment from mouse iPS cells.

机构信息

Lillehei Heart Institute, Department of Medicine, University of Minnesota, 4-124 Nils Hasselmo Hall, 312 Church St. S.E., Minneapolis, 55455 MN, USA.

出版信息

Stem Cell Rev Rep. 2011 Nov;7(4):948-57. doi: 10.1007/s12015-011-9258-2.

Abstract

Direct reprogramming of adult fibroblasts to a pluripotent state has opened new possibilities for the generation of patient- and disease-specific stem cells. However the ability of induced pluripotent stem (iPS) cells to generate tissue that mediates functional repair has been demonstrated in very few animal models of disease to date. Here we present the proof of principle that iPS cells may be used effectively for the treatment of muscle disorders. We combine the generation of iPS cells with conditional expression of Pax7, a robust approach to derive myogenic progenitors. Transplantation of Pax7-induced iPS-derived myogenic progenitors into dystrophic mice results in extensive engraftment, which is accompanied by improved contractility of treated muscles. These findings demonstrate the myogenic regenerative potential of iPS cells and provide rationale for their future therapeutic application for muscular dystrophies.

摘要

直接将成纤维细胞重编程为多能状态为生成患者特异性和疾病特异性干细胞开辟了新的可能性。然而,迄今为止,只有在极少数疾病的动物模型中证明了诱导多能干细胞(iPS 细胞)能够生成介导功能修复的组织。在这里,我们提出了一个原理证明,即 iPS 细胞可有效地用于肌肉疾病的治疗。我们将 iPS 细胞的生成与 Pax7 的条件表达相结合,这是一种强大的方法,可以衍生出成肌祖细胞。将 Pax7 诱导的 iPS 细胞衍生的成肌祖细胞移植到肌肉萎缩症小鼠中会导致广泛的植入,同时伴有治疗肌肉的收缩力提高。这些发现证明了 iPS 细胞的成肌再生潜力,并为其未来在肌肉萎缩症等疾病中的治疗应用提供了依据。

相似文献

1
Functional myogenic engraftment from mouse iPS cells.
Stem Cell Rev Rep. 2011 Nov;7(4):948-57. doi: 10.1007/s12015-011-9258-2.
3
Genomic Safe Harbor Expression of PAX7 for the Generation of Engraftable Myogenic Progenitors.
Stem Cell Reports. 2021 Jan 12;16(1):10-19. doi: 10.1016/j.stemcr.2020.11.001. Epub 2020 Dec 3.
5
Lack of PKCθ Promotes Regenerative Ability of Muscle Stem Cells in Chronic Muscle Injury.
Int J Mol Sci. 2020 Jan 31;21(3):932. doi: 10.3390/ijms21030932.
7
Muscle engraftment of myogenic progenitor cells following intraarterial transplantation.
Muscle Nerve. 2006 Jul;34(1):44-52. doi: 10.1002/mus.20560.
8
Myogenic Progenitors from Mouse Pluripotent Stem Cells for Muscle Regeneration.
Methods Mol Biol. 2016;1460:191-208. doi: 10.1007/978-1-4939-3810-0_14.
10
Direct Reprogramming of Mouse Fibroblasts into Functional Skeletal Muscle Progenitors.
Stem Cell Reports. 2018 May 8;10(5):1505-1521. doi: 10.1016/j.stemcr.2018.04.009.

引用本文的文献

2
Basic research for ultrasound-guided injection into skeletal muscle lesions in an experimental animal model.
Bone Joint Res. 2025 Jan 17;14(1):33-41. doi: 10.1302/2046-3758.141.BJR-2024-0090.R1.
3
Generation of highly pure pluripotent stem cell-derived myogenic progenitor cells and myotubes.
Stem Cell Reports. 2024 Jan 9;19(1):84-99. doi: 10.1016/j.stemcr.2023.11.002. Epub 2023 Dec 14.
4
Extracellular matrix: the critical contributor to skeletal muscle regeneration-a comprehensive review.
Inflamm Regen. 2023 Nov 27;43(1):58. doi: 10.1186/s41232-023-00308-z.
5
Organotypic cultures as aging associated disease models.
Aging (Albany NY). 2022 Nov 22;14(22):9338-9383. doi: 10.18632/aging.204361.
6
Recapitulating human myogenesis ex vivo using human pluripotent stem cells.
Exp Cell Res. 2022 Feb 15;411(2):112990. doi: 10.1016/j.yexcr.2021.112990. Epub 2021 Dec 30.
8
Pioneer factors in development and cancer.
iScience. 2021 Sep 15;24(10):103132. doi: 10.1016/j.isci.2021.103132. eCollection 2021 Oct 22.

本文引用的文献

2
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.
Cell Stem Cell. 2010 Nov 5;7(5):618-30. doi: 10.1016/j.stem.2010.08.012. Epub 2010 Sep 30.
4
Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
N Engl J Med. 2010 Oct 7;363(15):1397-409. doi: 10.1056/NEJMoa0908679. Epub 2010 Jul 21.
5
Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells.
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13426-31. doi: 10.1073/pnas.1007884107. Epub 2010 Jul 7.
6
Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury.
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12704-9. doi: 10.1073/pnas.0910106107. Epub 2010 Jul 6.
7
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.
Nature. 2010 Jun 10;465(7299):808-12. doi: 10.1038/nature09005.
8
Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells.
FASEB J. 2010 Jul;24(7):2245-53. doi: 10.1096/fj.09-137174. Epub 2010 Feb 24.
9
Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients.
Nature. 2010 Mar 11;464(7286):292-6. doi: 10.1038/nature08792. Epub 2010 Feb 17.
10
Direct cell reprogramming is a stochastic process amenable to acceleration.
Nature. 2009 Dec 3;462(7273):595-601. doi: 10.1038/nature08592. Epub 2009 Nov 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验